BICYCLE THERAPEUTICS PLC Quarterly Depreciation in USD from Q2 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Bicycle Therapeutics Plc quarterly/annual Depreciation history and growth rate from Q2 2018 to Q2 2024.
  • Bicycle Therapeutics Plc Depreciation for the quarter ending June 30, 2024 was $1.6M, unchanged year-over-year.
  • Bicycle Therapeutics Plc Depreciation for the twelve months ending June 30, 2024 was $6.6M, a 11.9% increase year-over-year.
  • Bicycle Therapeutics Plc annual Depreciation for 2023 was $6.5M, a 75.7% increase from 2022.
  • Bicycle Therapeutics Plc annual Depreciation for 2022 was $3.7M, a 164% increase from 2021.
  • Bicycle Therapeutics Plc annual Depreciation for 2021 was $1.4M, a 7.69% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $6.6M $1.6M $0 0% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $6.6M $1.7M +$100K +6.25% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $6.5M $1.6M +$200K +14.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-20
Q3 2023 $6.3M $1.7M +$400K +30.8% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $5.9M $1.6M +$1M +167% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $4.9M $1.6M +$1.2M +300% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $3.7M $1.4M +$900K +180% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-20
Q3 2022 $2.8M $1.3M +$1M +333% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $1.8M $600K +$300K +100% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $1.5M $400K +$100K +33.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $1.4M $500K +$100K +25% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-20
Q3 2021 $1.3M $300K $0 0% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $1.3M $300K $0 0% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $1.3M $300K $0 0% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $1.3M $400K +$400K Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 $900K $300K +$100K +50% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $800K $300K -$300K -50% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $1.1M $300K +$100K +50% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $1M $0 Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 $200K $0 0% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $600K +$400K +200% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 $200K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q3 2018 $200K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $200K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.